# FDA Inspection 1150563 - Hybrid Pharma LLC - September 03, 2021

Source: https://www.keypedia.com/records/fda_inspections/hybrid-pharma-llc/ba938ba0-4f15-436f-9784-4b4ffdeaf0d9
Source feed: FDA_Inspections

> FDA Inspection 1150563 for Hybrid Pharma LLC on September 03, 2021. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1150563
- Company Name: Hybrid Pharma LLC
- Inspection Date: 2021-09-03
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1222392 - 2023-11-09](https://www.keypedia.com/records/fda_inspections/hybrid-pharma-llc/4aa06683-906e-4099-a73c-5a091076a686)
- [FDA Inspection 1093987 - 2019-06-20](https://www.keypedia.com/records/fda_inspections/hybrid-pharma-llc/978cb167-fa24-4d74-94ff-b0396e011b27)
- [FDA Inspection 983055 - 2016-07-28](https://www.keypedia.com/records/fda_inspections/hybrid-pharma-llc/579d186a-aadb-4bb3-82f9-da4baf9e8455)

Company: https://www.keypedia.com/companies/hybrid-pharma-llc/c98f645e-a540-466e-bf3b-4b6b205cb5da

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c